The principal aim of this study was to clarify the time course of pain-related behavior and pain-related sensory innervation in a rat model of hip osteoarthritis (OA) induced by intra-articular injection of mono-iodoacetate (MIA). Using 6-week-old male Sprague Dawley rats, 25 ml of sterile saline of 1% Fluoro-Gold solution (FG) (control group; n ¼ 30) and 25 ml of sterile saline of 1% FG with 2 mg of MIA (MIA group; n ¼ 30) was injected into the right hip joints. Gait function was evaluated using a CatWalk system after 7, 14, 28, 42, and 56 days (n ¼ 5, respectively). Neurons in the dorsal root ganglion (DRG) between L1 and L5 were immunostained for calcitonin gene-related peptide (CGRP) and activating transcription factor-3 (ATF3). Gait analysis revealed the mean six parameters of hind paws at all time points were significantly lower in the MIA group (p ¼ 0.05). The number of CGRP-immunoreactive (-IR) DRG neurons was significantly increased on days 7, 14, 28, and 42 peaking at 14 days in the MIA group. By contrast, expression of ATF3-IR in FG-labeled DRG neurons was significantly increased on days 42 and 57. The FG-labeled DRG neurons were distributed between L1 and L5, mainly at the L4 level. Pain-related behavior indicated by gait disturbance was observed in a MIA model of hip OA in rat. Early elevation of CGRP expression and late expression of ATF-3 were demonstrated in DRG neurons, possibly reflecting inflammatory pain and neuropathic pain in hip OA. ß
Osteoarthritis (OA) is a common chronic degenerative disease characterized by loss of articular cartilage. 1, 2 Major clinical signs of hip OA are groin pain with weight bearing, restricted range of motion, and gait disturbance, [3] [4] [5] which deteriorates the quality of life of affected individuals. Referred pain may occur in OA. A recent study of the hip OA found that referred pain was localized to the groin (89%), buttock (38%), greater trochanter (27%), anterior thigh (33%), knee (29%), and lower back (17%), corresponding to the L1 to L5 dermatomes. 4 Therefore, in the clinic, it is sometimes difficult to diagnose pain originating from the hip. Basic research regarding hip pain is of great interest, but animal models of hip pain have been limited to those induced by intra-articular injection of nerve growth factor (NGF). 6 For knee OA, several animal models have been proposed, such as the model induced by anterior cruciate ligament transection, 7 the model induced by partial medial meniscectomy, 8 or a combination of both. 9 Mono-iodoacetate (MIA) has been commonly used to create a chemically-induced model of OA in rats by intra-articular injection into the knee. 10, 11 MIA inhibits the production of glyceraldehyde-3-phosphate dehydrogenase by articular chondrocytes, leading to disruption of glycolytic energy metabolism and synthetic processes, and eventually to cell death. 12 Intra-articular MIA injection to rats causes progressive loss of articular cartilage and subchondral lesions, resembling human knee OA.
Dorsal root ganglia (DRG) neurons are considered responsible for acute inflammatory pain. DRG neurons are divided into three categories: Peptide containing small neurons which are immunoreactive (IR) for calcitonin gene-related peptide (CGRP), 13, 14 nonpeptide containing small neurons that bind the isolectin B4 from Griffonia simplicifolia, 13, 15 and large neurons. CGRP has been reported to reflect acute inflammatory pain 16 in a rat model of knee OA induced by MIA. 17, 18 Activating transcription factor-3 (ATF3) is reported to be a selective marker of cell damage following nerve injury. 19 Chronic neuropathic pain increased the expression of ATF3-IR in DRG neurons in a rat model of knee OA induced by MIA. [20] [21] [22] However, to the best of our knowledge, these molecules have not been analyzed in a rat model of hip OA induced by MIA.
Pain-related behavior is useful to evaluate pain in animal models. Gait disturbance is widely accepted as a pain-related behavior. 23, 24 However, gait disturbance has not been examined in a rat model of hip OA induced by MIA. The purpose of this study was to clarify the time-course of pain-related behavior and pain-related sensory innervation after intra-articular injection of MIA into rat hip.
MATERIALS AND METHODS
All protocols for animal procedures were reviewed and approved by the ethics committee of our institution and followed the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals.
Intra-Articular Injection of MIA and Retrograde Neurotracer
We used 60 male Sprague Dawley (SD) rats weighing 200-300 g at 6 weeks of age (Clea, Tokyo, Japan). The protocols for the animal procedures in these experiments followed the 1996 revision of the National Institutes of Health guidelines for the Care and Use of Laboratory Animals and received approval from the ethics committee of our institution. Based on methods previously published elsewhere, 6 ,25 all rats were anesthetized with an intraperitoneal injection of sodium pentobarbital (40 mg/kg) and treated aseptically throughout the experiments. Using a 27-gauge needle, the following solutions were injected into the right hip joint of each rat using a posterior approach 6, 25 : 25ml of sterile saline with 2 mg of MIA (Sigma-Aldrich, St. Louis, MO) and 1% of the retrograde neurotracer FG (Fluorochrome, Denver, CO) in MIA group rats (n ¼ 30), and 25 ml of sterile saline with 1% of the retrograde neurotracer FG in the sham group rats (n ¼ 30). The injected fluid was restricted to the joint cavity. The doses of the drugs were based on previous literature. 21, 26, 27 Behavioral Testing Using CatWalk The CatWalk system (Noldus Information Technology, Wageningen, The Netherlands) is a computer-assisted gait analysis system that provides an automated way to assess gait function with the benefit of measuring a large number of both dynamic and static gait parameters simultaneously. Briefly, using this system, the rats are placed on a glass plate in a darkened room and allowed to walk freely. Light beams sent through the glass plate from a fluorescent lamp are normally completely reflected internally, but are reflected downward when a paw touches the glass plate, and as a result, the sharp bright image of a paw print is created. The whole run of a rat across the plate is recorded using a video camera. The data are acquired, compressed, and analyzed using CatWalk software (CatWalk, XT version 9.1; Noldus Information Technology) that generates static gait parameters such as contact area and paw pressure, and dynamic gait related to step duration. The software automatically presents a total of 21 gait parameters. Five rats from each group were recorded six times and their gait analyzed automatically using the CatWalk system at 7, 14, 28, 42, and 56 days after intra-articular injection. The ratio of the left hind paw (affected side) and the right hind paw (normal side) were taken as adjusted data for each parameter. At a baseline gait evaluation, the ratio was approximately 100%.
Calcitonin Gene-Related Peptide and Activating Transcription Factor-3 Immunohistochemistry of DRG Samples were prepared 7, 14, 28, 42, and 56 days after the intra-articular injection in five rats of each group. After deep anesthesia, the rats were perfused transcardially with 0.9% saline, followed by 500 ml of 4% paraformaldehyde in phosphate-buffer (0.1 M, pH 7.4). The right side DRGs between L1 and L5 were resected and prepared for immunohistology. The specimens were immersed in the phosphate-buffered paraformaldehyde fixative overnight at 4˚C. After storage in 0.01 M phosphate-buffered saline (PBS) containing 20% sucrose for 20 h at 4˚C, each DRG was sectioned at 12 mm on a cryostat (Leica Microsystems, CM3050S, Wetzlar, Germany) and mounted on polyl-lysine-coated slides. The specimens were then treated at room temperature with a blocking solution for nonspecific binding sites consisting of PBS containing 0.3% Triton X-100 and 3% skim milk for 90 min. They were processed for CGRP immunohistochemistry using rabbit antibody against CGRP (1:1000; Chemicon) or for ATF3 immunohistochemistry using a rabbit antibody against ATF3 (1:50; Santa Cruz, Delaware, CA). After incubation with the diluted antibodies for 20 h at 4˚C, DRG sections were incubated with Alexa 488-conjugated goat anti-rabbit IgG (for CGRP immunoreactivity, 1:1000; Molecular Probes) or Alexa 488-conjugated goat anti-rabbit IgG (for ATF3 immunoreactivity, 1:1000). After each step, the sections were rinsed in PBS three times and studied using fluorescence microscopy (Olympus, Tokyo, Japan) in a treatmentblinded manner. The numbers of FG-labeled CGRP-IR DRG neurons and FG-labeled ATF3-IR DRG neurons were counted.
Statistical Analysis
Differences in the CatWalk parameters between the two groups and the number of FG-labeled DRG neurons in the DRGs between L1 and L5 were evaluated using a TukeyKramer test. The proportions of CGRP-IR and ATF3-IR FG-labeled neurons in the DRGs were compared using a Mann-Whitney U-test followed by a Bonferroni correction. p < 0.05 was considered significant.
RESULTS

Behavioral Testing Using CatWalk
Six parameters in the CatWalk system showed significant differences: Standing time (stand), duty cycle, swing speed, print area, maximum contact area, and maximum intensity. Standing, which showed the duration in seconds of contact of a paw with the glass, was significantly higher in the MIA group than in the sham group (p < 0.05) at all time points after injection. In the MIA group, the standing time increased significantly with time (p < 0.05, Fig. 1A ). The duty cycle, which showed standing time as a percentage of step cycle: Stand/(stand þ swing) Â 100%, was significantly higher in the MIA group than in the sham group (p < 0.05) at all time points after injection. In the MIA group, the duty cycle increased significantly with time (p < 0.05, Fig. 1B) . The standing time and duty cycle related to the walking period. The swing speed, which showed the speed of the paw during swing, was significantly higher in the MIA group than in the sham group (p < 0.05) at all time points after injection. In the MIA group, the swing speed increased significantly with time (p < 0.05, Fig. 1C ). The swing speed related to stride. The print area, which showed the surface area of the complete print, was significantly higher in the MIA group than in the sham group (p < 0.05) at all time points after injection. In the MIA group, the print area increased significantly with time (p < 0.05, Fig. 1D ). The maximum contact area, which showed the maximum area of a paw (in the distance unit) that comes into contact with the glass plate, was significantly higher in the MIA group than in the sham group (p < 0.05) at all time points after injection. In the MIA group, the maximum contact area increased significantly with time (p < 0.05, Fig. 1E ). The maximum intensity, which showed the maximum intensity of the complete paw, was significantly higher PAIN INDICATORS IN A RAT MODEL OF HIP OSTEOARTHRITIS in the MIA group than in the sham group (p < 0.05) at all time points after injection. In the MIA group, maximum intensity increased significantly with time (p < 0.05, Fig. 1F ). The print area, maximum contact area, and maximum intensity related to the intensity of the paw print. As time progressed, the difference between two groups in three parameters gradually tended to decrease. Fig. 2 ). There were significantly more FG-labeled ATF3-IR DRG neurons between L1 and L5 in the MIA group than in the sham group on 42 and 56 days after injection (p < 0.05, Fig. 3 ). ATF3-IR DRG neurons were not observed in the MIA group on days 7 and 14 or in the sham group rats throughout the period examined.
DISCUSSION
MIA injection into the rat hip joints produced gait disturbance in walking period, stride, and intensity of paw print. This is the first report regarding painrelated behavior in a rat model of hip OA induced by MIA. The CatWalk system has been widely used to investigate the motor function in rats under various conditions, such as sciatic nerve injury, 28 spinal cord injury, 29, 30 myofascial inflammation, 23 intervertebral disc injury, 31 and inflammatory arthritis. 22, 32 In a model of myofascial inflammation, the duty cycle of front and hind paws, minimum contact intensity of the complete paw, and mean contact intensity of each paw were greater, but stride length (the distance between successive placements of the same paw) was shorter than in controls. 23 In a model of intervertebral disc injury, the standing times and the duty cycle were greater, but the stride length and the swing speed were shorter than in controls. 31 In a rat model of knee OA induced by MIA, the paw print intensity reduced from baseline and from the control at all time-points examined during 4 weeks. 22 The current study showed results in accordance with these previous reports.
CGRP-IR neurons, innervating the hip joint as seen by retrograde FG-labeling, significantly increased in number at the early phase from 7 to 42 days (peaking at 14 days). By contrast, ATF3-IR FG-labeled neurons were significantly increased during the late phase from 42 to 56 days after MIA injection. This is the first report describing pain-related sensory innervation in a rat model of hip OA induced by MIA. In a rat model of knee OA, Orita et al. observed similar findings in that the expression of CGRP-IR in ipsilateral DRG neurons increased early from 7 to 28 days. 21 Moreover, in a rat model of hip OA induced by NGF, CGRP-IR DRG neurons also increased early at 7 and 14 days. 6 CGRP is a typically used marker of NGF-dependent sensory neuron nociception 33, 34 and shows a hyperalgesic response to inflammation. [35] [36] [37] Pain from the hip in rats is mainly transmitted by CGRP-IR DRG neurons. 38 We suggest that elevation of CGRP expression is associated with an early phase of local inflammatory activity. CGRP-IR suggests the local inflammation may persist for 42 days.
In the current study, ATF-3 was probably expressed in the late phase after MIA injection because of a time lag between injury of nerve ending and the neuronal damage. ATF-3 was not actually observed during the acute phase. ATF-3 is dramatically induced in DRG neurons following a cellular response to nociceptive stimuli of peripheral nerves. 19 MIA seems to reproduce a nerve-injury-like response with some axonal damage as time progresses. These phenomena were similar to those seen in a rat model of knee OA induced by MIA. 21, 22 ATF-3 is also expressed in the DRG neurons in a model of arthritis induced by collagen 39 and in a model of chronic monoarthritic inflammatory joint pain. 40 Sensory innervation of the rat hip is distributed between levels L1 and L5, mainly at L4 as shown previously. 6, 38 These distributions did not change in the MIA group. Therefore, we suggest that the levels of sensory innervation are maintained even when hips are painful. CGRP-positive DRG neurons may have peripheral axons that dichotomize to innervate both the hip joint and the knee skin, and as such they are likely to play a role in the manifestation of referred pain to the knee. 41 There were several limitations to the current study. First, it was unclear which type of OA was induced by MIA injection into the rat hip. The model of knee arthritis induced by the MIA chemical method has been widely used in pain research because it is a rapid and easily reproducible method, and shows similar histopathology to human knee OA. 26, [42] [43] [44] [45] However, it is not likely that chronic hip OA secondary to acetabular dysplasia is represented, because the coxarthritis is rapidly destructive. Animal models of hip OA may help elucidate the molecular mechanism of hip pain, and may be essential tools in future research. Second, we only examined the DRGs between levels L1 and L5 because previous studies indicated that there were very few positive neurons at the thirteenth thoracic DRG and sixth lumbar DRG. 6, 38 A study is being currently conducted to evaluate the microglia in the dorsal horn. Third, pain-related molecules were only examined qualitatively. The level of inflammatory cytokines and their receptors, the macrophages and endothelial cell markers in synovium, cartilage, and bone should be investigated quantitatively using protein determination or gene expression. Finally, it was unknown which parameter is predictive for pain in the CatWalk system. However, it seems likely that the efficacy of various medications, anticytokine therapy, and other hip OA treatment strategies could be evaluated using this system. In conclusion, pain-related behavior involving gait disturbance was observed in the rat model of hip OA induced by MIA. Early CGRP expression and late ATF-3 expression were demonstrated by immunoreactivity in DRG neurons, possibly reflecting inflammatory and neuropathic pain in hip OA, respectively.
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